In order to elucidate whether BMSC-CM can induce HCC cell invasion through theIL-6 signaling pathway, we further compared the invasion ability ofBMSC-CM-treated, recombinant IL-6 treated and anti-IL-6 antibody treatedBel-7404 cells and HepG2 cells. Here, IL6 is linked to hepatocellular carcinoma.